In addition, a recent study by Chiang et al. showed that apigenin exerts anti-hepatoma activities via an apoptotic mechanism that is mediated through the p53-dependent pathway and the induction of p21 expression leading to cell cycle arrest in G2/M phase [55]. This evidence concerns the gene TP53 and hepatocellular carcinoma.